Connect with us

Hi, what are you looking for?

Jewish Business News

Business

Loeb, Einhorn and Ackman Fare Better in February After Dismal Start to 2015

The hedge fund managers have prospered with short positions, technology holdings

Daniel Loeb+ David Einhorn+ Bill Ackman

Hedge fund managers Bill Ackman, Daniel Loeb and David Einhorn saw significant returns in February according to ValueWalk. While Einhorn’s Greenlight Capital, Ackman’s Pershing Square and Daniel Loeb’s Third Point had a hiccup in January, all three posted gains for February.

Greenlight’s return for the year is a mere 0.38%, but that was because of a poor January. The first month of 2015 was Greenlight’s worst in a year on falling fuel prices, a stronger dollar and global uncertainty. In February, the fund gained 3.8%, and its main long positions are gold, Apple, Micron, Consol Energy and SunEdison.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.

Although Daniel Loeb’s Third Point fell 2.5% in January, it still outperformed the S&P 500, which dropped 3%. Loeb’s short positions outperformed the long positions and posted a slight gain for January. Third Point gained traction in February, and rose 4.8%. In a letter to investors, Loeb expressed concern about the stock market, which he compared to a “haunted house” because of its volatility. In January, he noted that the first 22 out of 25 trading days saw swings of 1%.

Bill Ackman’s Pershing Square was a top performing hedge fund last year, and he inspired others to imitate his aggressive activist approach. However, the fund slowed down a bit in January, gaining only 0.8%, but returning 5.6% total for the year as of February. Ackman is still determined to destroy Hebalife for what he considers unethical business practices, and he has a significant short position in the company.

 

Newsletter



You May Also Like

Life-Style Health

Medint’s medical researchers provide data-driven insights to help patients make decisions; It is affordable- hundreds rather than thousands of dollars

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Religion

He hopes to be a real Jew in time for Passover.

Leadership

Jews are disproportionately represented on the roster of the richest business people, with 10 Jews among the top 50 (20%), and 38 (19%) Jews...